This inventor holds 2 USPTO granted patents. Top assignees: Cenes Limited, Genes Limited. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2004
Title: Philip James Parsons: Innovator in Morphine-6-Glucuronide Synthesis
Introduction
Philip James Parsons is a notable inventor based in Heathfield, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of Morphine-6-Glucuronide. With a total of 2 patents to his name, Parsons has demonstrated a commitment to advancing medical science through innovative methods.
Latest Patents
Parsons' latest patents focus on a novel method for synthesizing Morphine-6-Glucuronide. The invention involves the reaction of 3-O-pivaloyloxymorphine and methyl 1α,2-ethylorthopivalate-3,4-di-O-pivaloylglucuronate. This method presents a significant advancement in the synthesis of this important compound, which has implications for pain management and therapeutic applications.
Career Highlights
Throughout his career, Philip James Parsons has worked with various companies, including Cenes Limited and Genes Limited. His work in these organizations has allowed him to collaborate with other professionals in the field and contribute to groundbreaking research.
Collaborations
One of his notable collaborators is Richard Andrew Ewin. Their partnership has likely fostered innovative ideas and advancements in their respective fields.
Conclusion
Philip James Parsons is a distinguished inventor whose work in Morphine-6-Glucuronide synthesis has the potential to impact the pharmaceutical industry significantly. His contributions reflect a dedication to innovation and the advancement of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile